Categories: Latest

SUPPLYSIDE WEST 2016: AstaPure® takes centre-stage at SupplySide West

New Delhi, August 23, 2016: Algatechnologies will showcase AstaPure® natural astaxanthin at Booth NN172 during the forthcoming SupplySide West (Las Vegas, 6-7 October 2016).

Visitors to the expo will have the opportunity to find out more about how AstaPure® astaxanthin is produced and how it can help them develop safe and effective nutrition products with a strong sustainability proposition and complete traceability.

Astaxanthin is a powerful antioxidant that delivers proven benefits in dietary supplements, functional food & drink products and cosmeceuticals across several categories, including sports nutrition, skin health, eye health, cardiovascular health and general wellbeing.

AstaPure®is a high quality and versatile astaxanthin ingredient available in multiple formats for use in a wide range of applications. Algatechnologies uses only super-critical CO2 technology, which obtains astaxanthin in an oleoresin form that leaves no solvent residues. It is Non-GMO Project Verified and certified as GMP, HACCP, ISO, Halal and Kosher.

Algatechnologies offers AstaPure®oleoresins in concentrations of 5%, 10% and 20%. These are ideal for use in easy-to-swallow softgel capsules and topical cosmetics (oil in water). AstaPure®can also be supplied in the form of 3% whole-algae powder, or free-flowing highly stable beadlets with 2.5% axtaxanthin for use in hard-shell capsules and tablets.

Algatechnologies produces astaxanthin from the microalgae strain Haematococcus pluvialis. Based in Israel’s Arava desert, Algatechnologies’ state-of-art ‘green’ production facility harnesses solar power to cultivate the microalgae in an enclosed system of photo bioreactors, ensuring maximum energy efficiency at all times. The microalgae are grown in fresh water sourced from a local borehole, 80% of which is purified and recycled for re-use.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

18 hours ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

2 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

2 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

3 days ago